“Bimekizumab for the Treatment of Moderate to Severe Plaque Psoriasis With Scalp, Nail and Palmoplantar Involvement Through 52 Weeks: Post-Hoc Analysis from the BE VIVID Phase 3 Trial”. SKIN The Journal of Cutaneous Medicine 5, no. 1 (January 1, 2021): s18. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1171.